OncoCyte: Funding, Investors & Team (Sep 2026)
OncoCyte is a biotechnology company that focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company's mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce the overall cost of care. OncoCyte was established in 2009 and is based in Alameda, California.
OncoCyte has raised $13.9M across 1 funding round on record, the most recent an undisclosed round of $13.9M announced in Apr 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OncoCyte Company Profile and Key Stats
Latest funding round on record: Apr 2023.
OncoCyte Funding Rounds
OncoCyte Founders and Leadership Team
Contact details for the OncoCyte team: 1 of 1 has an email address on file.
Start 14-day free trial →OncoCyte Funding Compared to Other Biotechnology Startups
OncoCyte's latest round of $13.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OncoCyte in Biotechnology and Irvine
Companies Similar to OncoCyte
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
OncoCyte Funding FAQs
What does OncoCyte do?
OncoCyte is a biotechnology company that focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company's mission is to provide actionable answers to physicians and patients at critical decision points along the lung cancer care continuum, to optimize diagnosis and treatment, improve patient outcomes, and reduce the overall cost of care. OncoCyte was established in 2009 and is based in Alameda, California.
How much funding has OncoCyte raised?
OncoCyte has raised $13.9M across 1 round on record. The most recent is an undisclosed round of $13.9M announced in Apr 2023.
When did OncoCyte last raise funding?
OncoCyte's most recent funding round on record is an undisclosed round of $13.9M, announced in Apr 2023.
Who is the CEO of OncoCyte?
Josh Riggs is listed as CEO at OncoCyte.
Where is OncoCyte headquartered?
OncoCyte is based in Irvine, California, United States.
How many employees does OncoCyte have?
OncoCyte is in the 51-100 employee band.
How does OncoCyte's funding compare to other Biotechnology startups?
OncoCyte's latest round of $13.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's OncoCyte Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OncoCyte is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.